Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1863)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (763)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 51 to 75 of 2384
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer
TA310
23 April 2014
23 April 2014
Aflibercept for treating choroidal neovascularisation
TA486
1 November 2017
1 November 2017
Aflibercept for treating diabetic macular oedema
TA346
22 July 2015
22 July 2015
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
TA409
28 September 2016
28 September 2016
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
TA305
26 February 2014
26 February 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy
TA307
25 March 2014
25 March 2014
Aflibercept solution for injection for treating wet age‑related macular degeneration
TA294
24 July 2013
24 July 2013
Age-related macular degeneration
NG82
23 January 2018
23 January 2018
Agomelatine for the treatment of major depressive episodes (terminated appraisal)
TA231
27 July 2011
27 July 2011
AI technologies for detecting diabetic retinopathy
MIB265
6 July 2021
6 July 2021
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images
DG55
5 July 2023
5 July 2023
Air pollution: outdoor air quality and health
NG70
30 June 2017
30 June 2017
Air pollution: outdoor air quality and health
QS181
28 February 2019
28 February 2019
Airglove air warming system for venous access
MIB151
6 July 2018
6 July 2018
Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions
MIB15
16 December 2014
16 December 2014
Alair bronchial thermoplasty system for adults with severe difficult to control asthma
MIB71
11 July 2016
11 July 2016
Alcohol interventions in secondary and further education
NG135
12 August 2019
12 August 2019
Alcohol-use disorders: diagnosis and management
QS11
24 August 2011
6 July 2023
Alcohol-use disorders: diagnosis and management of physical complications
CG100
2 June 2010
12 April 2017
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence
CG115
23 February 2011
21 October 2014
Alcohol-use disorders: prevention
PH24
2 June 2010
2 June 2010
Alcohol: preventing harmful use in the community
QS83
25 March 2015
25 March 2015
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)
TA438
29 March 2017
29 March 2017
Alectinib for untreated ALK-positive advanced non-small-cell lung cancer
TA536
8 August 2018
8 August 2018
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis
TA312
28 May 2014
21 May 2024
Previous page
1
2
Current page
3
4
5
…
96
Page
3
of
96
Next page
Results per page
10
25
50
All
Back to top